Materna Medical announces Oral Presentation Comparing Outcomes of Dilator-Experienced vs. Naïve Patients from an At-Home Study
A groundbreaking sub-analysis presented at the Sexual Medicine Society of North America (SMSNA) Annual Meeting demonstrates the efficacy of a new treatment in two distinct patient populations.
October 10, 2025 [Mountain View, Calif.]—Materna Medical announced today that an interim sub-analysis comparing dilator user types from the Prospective On Market Patient-reported Outcomes for Milli (POMPOM) clinical study will be presented orally at the Sexual Medicine Society of North America (SMSNA) Annual Meeting; the sub-analysis suggests a dramatic difference in effectiveness between the two user types.
The abstract, titled “POMPOM 3-Month Comparative Analysis of Static Dilator-Experienced vs. Naive Participants Using the Milli Expanding Vaginal Dilator,” evaluates outcomes in women with prior static dilator experience versus those new to dilation therapy with an at-home solution.
When experienced dilator users were asked why they purchased Milli, one POMPOM participant said, “[I] want to have more intermediate options than my static dilators, and [I] also want the vibration option.”
When asked to describe any impact that Milli has had on their sex life, one POMPOM participant reported, “Wonderful to have a gradual diameter change rather than a bunch of individual dilators that all need to be stored and cleaned.”
